Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alex Philippidis

Showing results (51-60 of 109) with videos related to

Pageof 11
Sort By:
Human Gene Therapy. Clinical Development|March 20, 2019
Gene Therapy BriefsAlex Philippidis
Human Gene Therapy|May 19, 2011
Developing a balanced business model for gene therapyAlex Philippidis
Human Gene Therapy|April 20, 2022
Bluebird Bio Chief Financial Officer Resigns as Company Raises "Going Concern" DoubtsAlex Philippidis
Human Gene Therapy|December 16, 2022
Brother of Cure Rare Disease CEO Dies in Trial of Duchenne Muscular Dystrophy TherapyAlex Philippidis
Human Gene Therapy|September 16, 2024
Pfizer Marks Phase III Success in Hemophilia A, then Layoffs after Failure in DMDAlex Philippidis
Human Gene Therapy|September 16, 2025
Vertex, Enlaza Launch Up-to-$2B Collaboration to Improve CASGEVY® ConditioningAlex Philippidis
Human Gene Therapy. Clinical Development|December 17, 2016
Gene Therapy BriefsAlex Philippidis
Human Gene Therapy|March 6, 2014
Gene therapy briefsAlex Philippidis
Human Gene Therapy|November 7, 2025
uniQure Gene Therapy Significantly Slows Huntington Disease ProgressionAlex Philippidis
Human Gene Therapy|December 22, 2021
National Institutes of Health, U.S. Food and Drug Administration, 15 Partners to Accelerate Development of Rare Disease Gene TherapiesAlex Philippidis
Pageof 11

Showing results (51-60 of 109) with videos related to

Sort By:
Pageof 11
Human Gene Therapy. Clinical Development|March 20, 2019
Gene Therapy BriefsAlex Philippidis
Human Gene Therapy|May 19, 2011
Developing a balanced business model for gene therapyAlex Philippidis
Human Gene Therapy|April 20, 2022
Bluebird Bio Chief Financial Officer Resigns as Company Raises "Going Concern" DoubtsAlex Philippidis
Human Gene Therapy|December 16, 2022
Brother of Cure Rare Disease CEO Dies in Trial of Duchenne Muscular Dystrophy TherapyAlex Philippidis
Human Gene Therapy|September 16, 2024
Pfizer Marks Phase III Success in Hemophilia A, then Layoffs after Failure in DMDAlex Philippidis
Human Gene Therapy|September 16, 2025
Vertex, Enlaza Launch Up-to-$2B Collaboration to Improve CASGEVY® ConditioningAlex Philippidis
Human Gene Therapy. Clinical Development|December 17, 2016
Gene Therapy BriefsAlex Philippidis
Human Gene Therapy|March 6, 2014
Gene therapy briefsAlex Philippidis
Human Gene Therapy|November 7, 2025
uniQure Gene Therapy Significantly Slows Huntington Disease ProgressionAlex Philippidis
Human Gene Therapy|December 22, 2021
National Institutes of Health, U.S. Food and Drug Administration, 15 Partners to Accelerate Development of Rare Disease Gene TherapiesAlex Philippidis
Pageof 11